These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17185151

  • 1. The effect of mesna on plasma total homocysteine concentration in hemodialysis patients.
    Urquhart BL, Freeman DJ, Spence JD, House AA.
    Am J Kidney Dis; 2007 Jan; 49(1):109-17. PubMed ID: 17185151
    [Abstract] [Full Text] [Related]

  • 2. Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients.
    Cutler MJ, Urquhart BL, Freeman DJ, Spence JD, House AA.
    Blood Purif; 2009 Jan; 27(3):306-10. PubMed ID: 19270449
    [Abstract] [Full Text] [Related]

  • 3. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K, Fragia T, Natse T, Bartholomatos G, Karagianni A, Katsaris G, Christidou F, Bamichas G, Stangou M, Papagalanis N.
    J Nephrol; 2002 Jan; 15(6):671-5. PubMed ID: 12495282
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 5. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006 Jun; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 6. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
    Sjöberg B, Anderstam B, Suliman M, Alvestrand A.
    Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
    [Abstract] [Full Text] [Related]

  • 7. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M.
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [Abstract] [Full Text] [Related]

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 9. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M, Stenvinkel P, Qureshi AR, Kalantar-Zadeh K, Bárány P, Heimbürger O, Vonesh EF, Lindholm B.
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [Abstract] [Full Text] [Related]

  • 10. Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
    House AA, Eliasziw M, Urquhart BL, Freeman DJ, Spence JD.
    Am J Kidney Dis; 2004 Oct; 44(4):689-94. PubMed ID: 15384020
    [Abstract] [Full Text] [Related]

  • 11. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A, Bilgic A, Sezer S, Arat Z, Ozdemir FN, Haberal M.
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Alteration of homocysteine before and after hemodialysis in chronic hemodialysis patients].
    Wang HT, Peng YM, Liu H.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):266-8. PubMed ID: 14653086
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
    Heinz J, Domröse U, Westphal S, Luley C, Neumann KH, Dierkes J.
    Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
    [Abstract] [Full Text] [Related]

  • 20. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
    Vianna AC, Mocelin AJ, Matsuo T, Morais-Filho D, Largura A, Delfino VA, Soares AE, Matni AM.
    Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.